Malaria is a mosquito-borne infectious disease that affects vertebrates and Anopheles mosquitoes. Human malaria causes symptoms that typically include fever, fatigue, vomiting, and headaches. In severe cases, it can cause jaundice, seizures, coma, or death. Symptoms usually begin 10 to 15 days after being bitten by an infected Anopheles mosquito. If not properly treated, people may have recurrences of the disease months later. In those who have recently survived an infection, reinfection usually causes milder symptoms. This partial resistance disappears over months to years if the person has no continuing exposure to malaria. The mosquito vector is itself harmed by Plasmodium infections, causing reduced lifespan.
Antimalarial medications or simply antimalarials are a type of antiparasitic chemical agent, often naturally derived, that can be used to treat or to prevent malaria, in the latter case, most often aiming at two susceptible target groups, young children and pregnant women. As of 2018, modern treatments, including for severe malaria, continued to depend on therapies deriving historically from quinine and artesunate, both parenteral (injectable) drugs, expanding from there into the many classes of available modern drugs. Incidence and distribution of the disease is expected to remain high, globally, for many years to come; moreover, known antimalarial drugs have repeatedly been observed to elicit resistance in the malaria parasite—including for combination therapies featuring artemisinin, a drug of last resort, where resistance has now been observed in Southeast Asia. As such, the needs for new antimalarial agents and new strategies of treatment remain important priorities in tropical medicine. As well, despite very positive outcomes from many modern treatments, serious side effects can impact some individuals taking standard doses.
Artemisia annua, also known as sweet wormwood, sweet annie, sweet sagewort, annual mugwort or annual wormwood, is a common type of wormwood native to temperate Asia, but naturalized in many countries including scattered parts of North America.
Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Artemisinin-based combination therapies (ACTs) are now standard treatment worldwide for P. falciparum malaria as well as malaria due to other species of Plasmodium. Artemisinin is extracted from the plant Artemisia annua an herb employed in Chinese traditional medicine. A precursor compound can be produced using a genetically engineered yeast, which is much more efficient than using the plant.
Chloroquine is an antiparasitic medication that treats malaria. It works by increasing the levels of haeme in the blood, a substance toxic to the malarial parasite. This kills the parasite and stops the infection from spreading. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It was studied to treat COVID-19 early in the pandemic, but these studies were largely halted in the summer of 2020, and the NIH does not recommend its use for this purpose. It is taken by mouth.
Primaquine is a medication used to treat and prevent malaria and to treat Pneumocystis pneumonia. Specifically it is used for malaria due to Plasmodium vivax and Plasmodium ovale along with other medications and for prevention if other options cannot be used. It is an alternative treatment for Pneumocystis pneumonia together with clindamycin. It is taken by mouth.
Entandrophragma cylindricum is a tree of the genus Entandrophragma of the family Meliaceae. It is commonly known as sapele or sapelli or sapele mahogany, as well as aboudikro, assi, and muyovu.
Khaya is a genus of five tree species in the mahogany family Meliaceae. The timber of Khaya is called African mahogany, and is valued as a substitute to American mahogany.
Quassia amara, also known as amargo, bitter-ash, bitter-wood, or hombre grande is a species in the genus Quassia, with some botanists treating it as the sole species in the genus. The genus was named by Carl Linnaeus who named it after the first botanist to describe it: the Surinamese freedman Graman Quassi. Q. amara is used as insecticide, in traditional medicine and as additive in the food industry.
Leonotis leonurus, also known as lion's tail and wild dagga, is a plant species in the mint family, Lamiaceae. The plant is a broadleaf evergreen large shrub native to South Africa, where it is very common. It is known for its medicinal properties. The main psychoactive component of Leonotis leonurus is hypothesized to be related to the presence of leonurine or labdanes, Leonotis leonurus has been confirmed to contain leonurine according to peer reviewed journal published phytochemical analysis. Like other plants in the mint family, it also contains marrubiin. The word "dagga" comes from Afrikaans, and derives in turn from the Khoikhoi "dachab". The word "dagga" has been extended to include cannabis in Afrikaans and South African English, so the use of "wild" serves to distinguish Leonotis leonurus from this.
Malaria vaccines are vaccines that prevent malaria, a mosquito-borne infectious disease which affected an estimated 249 million people globally in 85 malaria endemic countries and areas and caused 608,000 deaths in 2022. The first approved vaccine for malaria is RTS,S, known by the brand name Mosquirix. As of April 2023, the vaccine has been given to 1.5 million children living in areas with moderate-to-high malaria transmission. It requires at least three doses in infants by age 2, and a fourth dose extends the protection for another 1–2 years. The vaccine reduces hospital admissions from severe malaria by around 30%.
Khaya anthotheca, with the common name East African mahogany, is a large tree species in the Meliaceae family, native to tropical Africa.
Khaya ivorensis, also called African mahogany or Lagos mahogany, is a tall forest tree with a buttressed trunk in the family Meliaceae. It is found in Angola, Cameroon, Côte d'Ivoire, Gabon, Ghana, Liberia, and Nigeria where it grows primarily in lowland tropical rainforests. It is threatened by habitat loss.
Khaya senegalensis is a species of tree in the Meliaceae family that is native to Africa. Common names include African mahogany, dry zone mahogany, Gambia mahogany, khaya wood, Senegal mahogany, cailcedrat, acajou, djalla, and bois rouge.
Swietenia macrophylla, commonly known as mahogany, Honduran mahogany, Honduras mahogany, or big-leaf mahogany is a species of plant in the Meliaceae family. It is one of three species that yields genuine mahogany timber (Swietenia), the others being Swietenia mahagoni and Swietenia humilis. It is native to South America, Mexico and Central America, but naturalized in the Philippines, Singapore, Malaysia and Hawaii, and cultivated in plantations and wind-breaks elsewhere.
Vernonia amygdalina, a member of the daisy family, is a small to medium-sized shrub that grows in tropical Africa. V. amygdalina typically grows to a height of 2–5 m (6.6–16.4 ft). The leaves are elliptical and up to 20 cm (7.9 in) long. Its bark is rough.
Cryptolepis sanguinolenta is a species of flowering plant in the family Apocynaceae. An extract from the root is traditionally used in West Africa for malaria.
Picralima is a plant genus in the family Apocynaceae, first described as a genus in 1896. It contains only one known species, Picralima nitida, native to tropical Africa.
Carapa guianensis is a species of tree in the family Meliaceae, also known by the common names andiroba or crabwood.
Gedunin is a pentacyclic triterpenoid with the molecular formula C28H34 O7. It is most notably found in Azadirachta indica, but is a constituent of several other plants. Gedunin shows therapeutic potential in the treatment of leukemia, and Parkinson's disease.
